83513-009 : Beizray 20 mg/ml Intravenous Injection, Solution


NDC: 83513-009
Labeler: Zhuhai Beihai Biotech Co., Ltd.
Product Type: Human Prescription Drug
Drug Name:  Beizray
Dosage Form: Intravenous Injection, Solution
Application #: NDA218711
Rev. Date: 


NDC Package Codes:

  • 83513-009-01: 4 ML IN 1 VIAL, GLASS (83513‑009‑01)

Active Ingredients:

  • Docetaxel Anhydrous

Dosage Strength:

  • 20 mg/mL

Pharmaceutical Classes:

  • Microtubule Inhibition [PE]
  • Microtubule Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 83513-008 Beizray 20 mg/ml Intravenous Injection, Solution by Zhuhai Beihai Biotech Co., Ltd.
  • 83513-010 BeizrayBeizray Intravenous Kit by Zhuhai Beihai Biotech Co., Ltd.
  • 70710-2091 BeizrayBeizray Kit by Zydus Pharmaceuticals USA Inc.
  • 70710-2092 Beizray 20 mg/ml Intravenous Injection, Solution by Zydus Pharmaceuticals USA Inc.
  • 70710-2093 BeizrayBeizray Kit by Zydus Pharmaceuticals USA Inc.
  • 70710-2152 Beizray 20 mg/ml Intravenous Injection, Solution by Zydus Pharmaceuticals USA Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 83513-009 QR Code

< Prev: 83513-008Next: 83513-010 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.